Peter Mørch Eriksen has two successful turnarounds on his CV - in the 90s for technology firm Brüel & Kjær, while the diagnostic division in Medtronic came under the care of the commercial expert later on. Now the time has come for BioPorto to make use of his expertise. Peter Mørch Eriksen has already decided on the overall steps for advancement of the distressed diagnostics company.
“I believe we have to reach out to more doctors. BioPorto is represented in 80 countries, and the 80-20 rule applies in this case as well, I suppose. We have to focus our efforts on specific markets, and we have to be a lot more focused on a gradual approach to our growth, instead of spreading it out,” Peter Mørch Eriksen explains.